Medicare Enrolled
Dr. Andrew Messiha, MD
Pain Medicine · Laguna Hills, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Messiha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Messiha?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Messiha
Dr. Andrew Messiha is a pain medicine specialist in Laguna Hills, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Messiha performed 2,826 Medicare services across 961 unique beneficiaries.
Between the years covered by Open Payments, Dr. Messiha received a total of $20,000 from 69 pharmaceutical and/or device companies across 554 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Messiha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 19% volume in CA
$20,000 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,826
Medicare services
Top 19% in CA for pain medicine
961
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~177 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,410 | $104 | $379 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
628 | $0 | $1 |
| New patient office visit, complex (60-74 min) | 133 | $185 | $694 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
126 | $150 | $504 |
| Psychological test evaluation, first hour A healthcare professional evaluates the results of psychological testing during an initial one-hour session. |
124 | $100 | $364 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
97 | $82 | $900 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
45 | $0 | $3 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
43 | $94 | $834 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
38 | $43 | $365 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
33 | $90 | $910 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
30 | $48 | $220 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
22 | $27 | $105 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
21 | $83 | $340 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
21 | $75 | $652 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
20 | $105 | $671 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
19 | $58 | $326 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
16 | $165 | $1,564 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,000
Total received (2018-2024)
Avg $2,857/year across 7 years
Top 9% in CA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
554
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,000 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,648
2023
$3,372
2022
$1,898
2021
$3,382
2020
$1,609
2019
$5,675
2018
$1,416
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Saluda Medical Americas, Inc.
$975
Abbott Laboratories
$443
Boston Scientific Corporation
$345
Curonix LLC
$271
BIOTRONIK NRO, Inc.
$221
ABBVIE INC.
$84
VERTEX PHARMACEUTICALS INCORPORATED
$77
Collegium Pharmaceutical, Inc.
$77
Nevro Corp.
$47
SCILEX PHARMACEUTICALS INC.
$43
Avanos Medical
$29
Vertos Medical, Inc.
$16
PFIZER INC.
$14
SPR Therapeutics, Inc
$7
Top 3 companies account for 66.6% of 2024 payments
All-time payments by company (2018-2024) ›
Saluda Medical Americas, Inc.
$2,632
Boston Scientific Corporation
$2,544
Abbott Laboratories
$2,180
Medtronic USA, Inc.
$1,641
Nevro Corp.
$1,616
BOSTON SCIENTIFIC CORPORATION
$961
Medtronic, Inc.
$825
Collegium Pharmaceutical, Inc.
$595
SI-BONE, Inc.
$553
Curonix LLC
$500
ABBVIE INC.
$470
SCILEX PHARMACEUTICALS INC.
$361
Vertiflex, Inc.
$358
Almatica Pharma LLC
$332
PFIZER INC.
$316
Allergan, Inc.
$236
BIOTRONIK NRO, Inc.
$221
Kaleo, Inc.
$214
Amgen Inc.
$204
Scilex Pharmaceuticals Inc.
$203
AbbVie Inc.
$201
Daiichi Sankyo Inc.
$175
Flexion Therapeutics, Inc.
$174
Biohaven Pharmaceutical Holding Company Ltd.
$168
BioDelivery Sciences International, Inc.
$141
SI-BONE, INC.
$138
Merck Sharp & Dohme Corporation
$120
Merz Pharmaceuticals, LLC
$117
Biohaven Pharmaceuticals, Inc.
$117
FIDIA PHARMA USA INC.
$113
Mallinckrodt Enterprises LLC
$111
Piramal Critical Care
$93
West Therapeutics Development, LLC
$84
Allergan Inc.
$80
VERTEX PHARMACEUTICALS INCORPORATED
$77
DePuy Synthes Sales Inc.
$74
Vertos Medical, Inc.
$72
GRT US Holding, Inc.
$71
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$68
Lilly USA, LLC
$61
Stimwave Technologies Incorporated
$61
US WorldMeds, LLC
$52
Mallinckrodt LLC
$48
ASSERTIO THERAPEUTICS, Inc.
$45
IMPEL PHARMACEUTICALS INC.
$45
Avanos Medical
$43
Pacira Therapeutics, Inc.
$43
AcelRx Pharmaceuticals, Inc.
$42
Novartis Pharmaceuticals Corporation
$42
SPR Therapeutics, Inc
$34
Teva Pharmaceuticals USA, Inc.
$32
USWM, LLC
$32
ARBOR PHARMACEUTICALS, INC.
$30
BAXTER HEALTHCARE
$22
Fidia Pharma USA Inc.
$18
Zyla Life Sciences
$17
Nalu Medical, Inc.
$17
Pacira Pharmaceuticals Incorporated
$16
Horizon Therapeutics plc
$15
Zyla Life Sciences, Inc.
$15
Horizon Pharma plc
$15
IBSA Pharma Inc.
$14
RedHill Biopharma Inc.
$14
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$13
Forte Bio-Pharma LLC
$12
INSYS Therapeutics Inc
$11
FORTE BIO-PHARMA LLC
$11
AstraZeneca Pharmaceuticals LP
$11
Nuvectra Corporation
$9
Top 3 companies account for 36.8% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · Aimovig · Algovita · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · COMIRNATY · COOLIEF* COOLED RADIOFREQUENCY · DSUVIA · DUEXIS · EMGALITY · ETERNA · EVZIO · Evoke · Evoke SCS · Evzio · Exparel · FLOSEAL · GABLOFEN · GABLOFEN 1 mL in 1 SYRINGE · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GENERATOR · GLASS · GRALISE · General - Pain Management · Gralise · HYMOVIS · Horizant · Hymovis · INTELLIS · INTELLIS ADAPTIVESTIM · Infinion 16 · KEYTRUDA · LYRICA · Licart · Lucemyra · Lucemyra/Lofexidine · MAZOR X SYSTEM · MOVANTIK · Morphabond ER · Movantik · N'VISION · NAPRELAN · NURTEC ODT · Nalocet · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · NuDyn · Nucynta · OFIRMEV · ORTHOVISC · Omnia · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PROLATE · Proclaim Family of SCS IPGs · Proclaim IPG · Prospera · QULIPTA · Qutenza · RAYOS · RELISTOR · RESTORE · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUBSYS · SUPERION · SYMJEPI · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · Subsys · Superion ISS · Superion Indirect Decompression System · Trudhesa · UBRELVY · VANTA ADAPTIVESTIM · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · Xeomin · ZIMHI · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for pain medicine in CA.
Geographic Context
Pain medicines within 10 mi
51
Per 100K population
1.6
County median income
$113,702
Nearest hospital
MEMORIALCARE SADDLEBACK MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Messiha is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Messiha experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Messiha performed 1,410 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Messiha receive payments from pharmaceutical companies?
Yes. Dr. Messiha received a total of $20,000 from 69 companies across 554 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Messiha's costs compare to other pain medicines in Laguna Hills?
Dr. Messiha's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Messiha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Laguna Hills
Browse pain medicines in Laguna Hills ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in CA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in CA
Which CA pain medicines receive the most from drug and device companies.
By company
Saluda Medical Americas, Inc. Payments to Doctors
See all physicians who received payments from Saluda Medical Americas, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology